Savara Inc (SVRA) Net Margin
- 2020-12-31: Net Margin -1374100.00%.
- 2020-09-30: Net Margin -4321.48%.
- 2017-03-31: Net Margin -5291.49%.
- 2016-12-31: Net Margin -1117.75%.
Complete source-backed net margin history.
- Available history
- 2010-12-31 to 2020-12-31
- Data captured
Historical Net Margin
| Date | Net Margin |
|---|---|
| 2020-12-31 | -1374100.00% |
| 2020-09-30 | -4321.48% |
| 2017-03-31 | -5291.49% |
| 2016-12-31 | -1117.75% |
| 2016-09-30 | -7171.11% |
| 2015-12-31 | 38296.30% |
Annual Net Margin
| Date | Net Margin |
|---|---|
| 2020-12-31 | -19305.45% |
| 2016-12-31 | -2730.75% |
| 2015-12-31 | -16664.81% |
| 2010-12-31 | -1728.35% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |